HEALTHCARE

Seven severely ill patients treated with Enlivex's Allocetra, which stops the immune system running out of control, have fully recovered.

1,568 people tested positive for the virus yesterday, Israel's Ministry of Health reports, the largest number of new infections since mid-October.

Biosight, based at Airport City near Tel Aviv, is developing innovative cancer therapeutics for hematological malignancies and disorders.

The Caesarea-based company has developed a medical valve that is inserted into a catheter for symptomatic patients with primary or secondary mitral regurgitation.

Incoming National Council for Civilian R&D chair Prof. Peretz Lavie warns that Israel's "startup nation" image masks severe under-investment.

The number of excess deaths fairly closely matches the number of reported deaths from Covid-19.

Israel Institute of Biological Research director general Prof. Shmuel Shapira is frustrated by over-regulation and the preference for foreign-made vaccines.

Black Friday spending in Israel was down 10% on last year, according to credit card data.

The agreement was with Cephalon, which Teva subsequently acquired, concerning sleep disorder treatment modanifil.

AstraZeneca Israel CEO Ohad Goldberg says Israel ordered 10 million doses directly, after discovering WHO-program factories did not meet Health Ministry standards.

The Israeli company produces meat alternatives from an innovative plant based formula, a smart robot for 3D printing, and roasting using advanced cooking methods.

The Israeli venture capital fund and the pharmaceutical giant will invest in nine early stage startups.

The lab test company's chairman Moshe Ben Shaul and CEO Tammy Galili, father and daughter, tell "Globes" how change means opportunity.

CEO Dr. Liat Goldshaid-Zmiri describes how a casual e-mail led to aesthetic medicine company Luminera's acquisition by AbbVie.

The former Teva Israel CEO, now CEO of Tikun Olam Cannbit, talks about the business and therapeutic potential of medical cannabis.

Tal Ohana did not sit around waiting for the government to act and has transformed Yeruham from a 'red' city to 'green' by taking responsibility for the situation.

Prof. Adam de la Zerda talks about the device that could be a game-changer in the fight against Covid-19.

Immunai helps drug companies make immune therapies more accurate and customized.

SaverOne claims to have the long-sought solution to drivers being distracted by their phones. Now it's up to the regulators.

Covid-19 has made sleep clinics risky, which is where Itamar Medical's disposable home sleep apnea diagnosis kit comes in.

Complex systems expert Dr. Yaneer Bar-Yam believes "flattening the curve" is immoral and futile, and that we have a better choice.

As Covid-19 rages, companies with solutions meet hospitals with problems on digital health community platform HealthIL.

In opposition, Naftali Bennett has gained popularity with policies to combat the virus, and is unscathed from his role in the government, which opened the economy.

The Intel SVP tells "Globes" that the million Israelis with underlying conditions who are endangered by Covid-19 should be given special protection.

MSD executive Dr. Eliav Barr describes his company's coronavirus vaccine strategy, and possible threats to come.

Founder Gil Kerbs tells "Globes" about Newt and its personalized nutrition app, which provides motivation as well as menus.

Good results, falling debt and Covid-19 have all contributed to the Israeli drugmaker's share price nearly doubling since March.

Former Prime Minister Ehud Olmert, a consultant to medical cannabis firm Univo, regrets the delay on export permits.